Rapid Nexus

📍 Irvine, United States👥 7 employees💰 Last funded Jun 2020
Medical Equipment Manufacturing🌐 rapidnexus.com
Website LinkedIn
The current management of chronic wound healing is not effective and often requires surgical approaches. Rapid Nexus Nanotech Wound Solutions. has a groundbreaking approach to treating complex non-healing chronic wounds including diabetic ulcers. Our wound management system does not require debridement. It limits infection, stimulates wound re-epithelialization, cell proliferation, extracellular matrix production and improves vascularization. The Rapid Nexus wound management system already has eliminated the need for amputations in our own patient studies. Patients or their caregivers can be trained to apply topical treatment along with our small device to stimulate uptake of the topical gel composition by the wound bed.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Rapid Nexus?
Rapid Nexus has 1 investors on record on gritt.io, 1 mid-stage.
When did Rapid Nexus last raise funding?
The most recent investment in Rapid Nexus recorded on gritt.io was in June 2020.
What industry is Rapid Nexus in?
Rapid Nexus operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Rapid Nexus based?
Rapid Nexus is headquartered in Irvine, United States.